The mesothelioma and radical surgery randomized controlled trial: The MARS feasibility study

Journal of Thoracic Oncology

Volumn 4, Issue 10, 2009, Pages 1254-1258

  Treasure, Tom ^a,i   Waller, David ^b   Tan, Carol ^a   Entwisle, James ^b   Obrien, Mary ^c   Obyrne, Ken ^d   Thomas, Gill ^b   Snee, Michael ^e   Spicer, James ^f   Landau, David ^a   Lang Lazdunski, Loïc ^a   Bliss, Judith ^g   Peckitt, Clare ^g   Rogers, Shaun ^g   Marriage, Erica ^h   Coombes, Gillian ^g   Webster Smith, Mark ^g   Peto, Julian ^g  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b GLENFIELD HOSPITAL   (United Kingdom)

^c ROYAL MARSDEN HOSPITAL   (United Kingdom)

^d ST JAMES S HOSPITAL   (Ireland)

^e ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^f KING'S COLLEGE LONDON   (United Kingdom)

^g INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^h AVON AND WILTSHIRE MENTAL HEALTH PARTNERSHIP NHS TRUST   (United Kingdom)

ⁱ UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Extrapleural pneumonectomy.; Multimodality therapy; Pleural mesothelioma; Randomized controlled trial

Indexed keywords

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEASIBILITY STUDY; HUMAN; INFORMED CONSENT; INOPERABLE CANCER; LUNG RESECTION; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STANDARD; UNITED KINGDOM;

EID: 70349687645     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3181ae26ae     Document Type: Article

References (21)

1. Tsao AS, Wistuba I, Roth JA, Kindler HL. Malignant pleural mesothe-lioma. J Clin Oncol 2009;27:2081-2090.
2. Hodgson JT, McElvenny DM, Darnton AJ, Price MJ, Peto J. The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050. Br J Cancer 2005;92:587-593.
3. Peto J, Decarli A, La Vecchia C, Levi F, Negri E. The European mesothelioma epidemic. Br J Cancer 1999;79:666-672.
4. Rake C, Gilham C, Hatch J, Darnton A, Hodgson J, Peto J. Occupational, domestic and environmental mesothelioma risks in the British population: a case-control study. Br J Cancer 2009;100:1175-1183.
5. Butchart EG, Ashcroft T, Barnsley WC, Holden MP. Pleuropneumonec-tomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients. Thorax 1976;31:15-24.
6. Ahamad A, Stevens CW, Smythe WR, et al. Promising early local control of malignant pleural mesothelioma following postoperative intensity modulated radiotherapy (IMRT) to the chest. Cancer J 2003;9: 476-484.
7. Aziz T, Jilaihawi A, Prakash D. The management of malignant pleural mesothelioma; single centre experience in 10 years. Eur J Cardiothorac Surg 2002;22:298-305. (Pubitemid 34831874)
8. Maggi G, Casadio C, Cianci R, Rena O, Ruffini E. Trimodality management of malignant pleural mesothelioma. Eur J Cardiothorac Surg 2001;19:346-350.
9. Rusch VW, Rosenzweig K, Venkatraman E, et al. A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2001;122: 788-795.
10. Sugarbaker DJ, Flores RM, Jaklitsch MT, et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 1999;117:54-63.
11. Rice DC, Stevens CW, Correa AM, et al. Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma. Ann Thorac Surg 2007;84:1685-1692.
12. Treasure T, Sedrakyan A. Pleural mesothelioma: little evidence, still time to do trials. Lancet 2004;364:1183-1185.
13. Glasziou P, Chalmers I, Rawlins M, McCulloch P. When are randomised trials unnecessary? Picking signal from noise. BMJ 2007;334:349-351.
14. Treasure T, Utley M. Ten traps for the unwary in surgical series: a case study in mesothelioma reports. J Thorac Cardiovasc Surg 2007;133: 1414-1418.
15. Horton R. Surgical research or comic opera: questions, but few answers. Lancet 1996;347:984-985.
16. Flores RM, Zakowski M, Venkatraman E, et al. Prognostic factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center. J Thorac Oncol 2007;2:957-965.
17. Flores RM, Pass HI, Seshan VE, et al. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. J Thorac Cardiovasc Surg 2008;135:620 - 626, 626.e1-3
18. Martin-Ucar AE, Nakas A, Edwards JG, Waller DA. Case-control study between extrapleural pneumonectomy and radical pleurectomy/decorti-cation for pathological N2 malignant pleural mesothelioma. Eur J Car-diothorac Surg 2007;31:765-770.
19. Schipper PH, Nichols FC, Thomse KM, et al. Malignant pleural me-sothelioma: surgical management in 285 patients. Ann Thorac Surg 2008;85:257-264.
20. Nakas A, Trousse DS, Martin-Ucar AE, Waller DA. Open lung-sparing surgery for malignant pleural mesothelioma: the benefits of a radical approach within multimodality therapy. Eur J Cardiothorac Surg 2008; 34:886-891.
21. Treasure T, Utley M. Mesothelioma: benefit from surgical resection is questionable. J Thorac Oncol 2007;2:885-886.